
About thinkMolecular
thinkMolecular is a company based in Bengaluru (India) founded in 2020 by Ramesh Sistla. It operates as a B2B. The company has 1 employees. thinkMolecular offers products and services including Target Identification and Validation, Hit Generation, Lead Generation, Lead Optimization, and Chemical Biology. thinkMolecular operates in a competitive market with competitors including Owkin, Formation Bio, AbSci, BigHat and Predictive Oncology, among others.
- Headquarter Bengaluru, India
- Employees 1
- Founders Ramesh Sistla
- SectorsTechnologyHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website thinkmolecular.in
- Social LinkedIn
- Legal Name Thinkmolecular Technologies Private Limited
- Date of Incorporation 01 Aug, 2020
- Jurisdiction Bengaluru, Karnataka, India
- Annual Revenue₹2.13 Cr
FY 2024 · +104% YoY
- Net Profit₹92.6 Lakh
FY 2024 · 44% margin
- EBITDA₹1.26 Cr
FY 2024 · 59% margin
- Employee Count1
Associated legal entities of thinkMolecular
thinkMolecular operates through Thinkmolecular Technologies Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Thinkmolecular Technologies Private Limited CIN U73100KA2020PTC136742 | Active | 01 Aug 2020 | Bengaluru, Karnataka | ₹2.1 Cr | – | 2 | View details |
Products & Services of thinkMolecular
thinkMolecular offers a comprehensive portfolio of products and services, including Target Identification and Validation, Hit Generation, Lead Generation, Lead Optimization, and Chemical Biology.
Analyzes data to identify and validate drug targets for informed profiles.
Screens compounds using CADD for identifying potential hits.
Optimizes hits into leads via design and selectivity techniques.
Enhances leads focusing on activity, DMPK, and adverse event mitigation.
Designs experiments based on molecular structures for target issues.
Board of directors of Thinkmolecular Technologies Private Limited (thinkMolecular)
Thinkmolecular Technologies Private Limited is the primary company behind thinkMolecular. The board of Thinkmolecular Technologies Private Limited currently have 2 directors; the longest-serving is Ravi Shankar Sistla, appointed in 2020.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ravi Shankar Sistla DIN 02181717 | Director | 01 Aug 2020 | 6 yrs 2 mo | Thinkmolecular Technologies Private Limited |
| Ramesh Kumar Sistla DIN 08818906 | Managing Director | 01 Aug 2020 | 6 yrs 2 mo | Thinkmolecular Technologies Private Limited |
People of thinkMolecular
1 people are tracked at thinkMolecular (1 in leadership); the tracked headcount is 1.
| Name | Role | Group |
|---|---|---|
| Founder, Managing Director | Leadership |
Complete people profiles for thinkMolecular
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of thinkMolecular
Figures of Thinkmolecular Technologies Private Limited, the primary company behind thinkMolecular, for FY 2024. Revenue was ₹2.13 Cr (+104% year on year). Net profit was ₹92.6 Lakh (44% margin). EBITDA was ₹1.26 Cr (59% margin). Revenue has grown at a compounded annual rate of +205% over three years.
- ₹2.13 CrRevenue · FY 2024 · +104% YoY
- ₹92.6 LakhNet profit · 44% margin
- ₹1.26 CrEBITDA · 59% margin
- ₹5 LakhPaid-up capital
- +205%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Thinkmolecular Technologies Private Limited are on its company page.
Detailed financial statements for thinkMolecular
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of thinkMolecular
thinkMolecular operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Owkin, Formation Bio, AbSci, BigHat and Predictive Oncology, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| owkin.com | 2016 | Paris, France | $321.1M | 47 | An agentic AI platform is developed for biomedical research insights. | |
| formation.bio | 2016 | New York, United States | $608M | – | AI-powered drug discovery platform for various diseases | |
| absci.com | 2011 | Vancouver, United States | $227.56M | 256 | AI-based technology is used for recombinant protein production in therapeutics. | |
| bighatbio.com | 2019 | San Carlos, United States | $148.41M | – | Antibody therapies are developed through machine learning and synthetic biology. | |
| predictive-oncology.com | 2002 | Eagan, United States | $43M | 31 | AI-based platform for cancer diagnostics and precision medicine is utilized. | |
| benchsci.com | 2015 | Toronto, Canada | $157.73M | – | AI platform used for extracting antibody data from scientific papers. | |
| xtalpi.com | 2014 | Cambridge, United States | $783.5M | 33 | AI-driven crystal structure prediction for pharmaceutical development is offered. | |
| iambic.ai | 2019 | San Diego, United States | $206.23M | 50 | AI-driven drug discovery platform for the treatment of cancer | |
| exscientia.com | 2012 | Oxford, United Kingdom | $428.63M | 392 | AI-driven drug discovery and precision medicine solutions are provided. |
Detailed competitors of thinkMolecular
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to thinkMolecular
10 companies that operate in the same segment as thinkMolecular (AI in Life Sciences), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provides AI solutions and services for research publishing and communication. | 2001 | Mumbai, Maharashtra, India | – | USD 91.43 M | 1,025 | |
High-performance computing research is conducted by BSC in Barcelona. | 2005 | Barcelona, Catalonia, Spain | – | – | – | |
Scientific communications, localization, and AI services for researchers and publishers. | 2000 | Mumbai, Maharashtra, India | – | USD 25.46 M | 243 | |
Fullpower-AI is recognized as a leading AI-biosensing platform company. | 2003 | Santa Cruz, California, United States | USD 25 M | – | – | |
Drug candidates are optimized via machine learning-enhanced medicinal chemistry. | 2020 | Durham, North Carolina, United States | USD 5.5 M | – | – | |
Provides big data analytics solutions tailored for the life sciences sector. | 2006 | Bengaluru, Karnataka, India | – | – | – | |
AI-powered drug intelligence platform for life science professionals | – | Beijing, China | – | – | – | |
Resource and marketplace for lab tools, services, and research news. | 2013 | Bengaluru, Karnataka, India | – | – | – | |
Live cell imaging solutions are delivered via an AI-based platform. | – | Wilmington, Delaware, United States | – | – | – | |
PR agency offering AI-assisted communications and media services for biotech companies. | 2023 | Singapore, Singapore | – | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about thinkMolecular
thinkMolecular was founded in 2020.
thinkMolecular is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
thinkMolecular has 1 employees.
The primary company behind thinkMolecular, Thinkmolecular Technologies Private Limited, reported revenue of βΉ2.13 Cr for FY 2024, up 104% year on year.
Think Molecular specializes in molecular simulations to advance drug discovery processes. They use AI and machine learning to analyze genomic and structural data for tasks like target identification, hit generation, and lead optimization. The company provides services such as chemical biology experiments and scientific due diligence, primarily targeting pharmaceutical entities. Based in India, they enable efficient decision-making through computational tools and consultations.
thinkMolecular's top competitors include Owkin, Formation Bio and XtalPi.
thinkMolecular offers Target Identification and Validation, Hit Generation, Lead Generation, Lead Optimization, and Chemical Biology.
thinkMolecular operates through Thinkmolecular Technologies Private Limited.
The legal entities of thinkMolecular currently have 2 directors, including Ravi Shankar Sistla, Ramesh Kumar Sistla.